Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

8 Jan 2016 17:19

LONDON MARKET CLOSE: China Woes See FTSE 100 Fall Over 5% On The Week

Read more
8 Jan 2016 15:11

FTSE 250 movers: Zoopla helps keep market marginally in the black

(ShareCast News) - The FTSE 250 remained in the black by mid-afternoon, but only just with the market up 0.27 points (0.00%) to 16,792.49. Zoopla Property Group surged nearly 7% after Berenberg issued an analysis of the media sector and reiterated its 'buy' rating for the property classifieds websit

Read more
8 Jan 2016 12:13

LONDON MARKET MIDDAY: Stocks Give Up Gains Ahead Of US Jobs Report

Read more
8 Jan 2016 10:25

WINNERS & LOSERS SUMMARY: Broker Upgrades Boost Tesco And GKN

Read more
8 Jan 2016 08:30

LONDON MARKET OPEN: Tesco Leads Gains After Barclays Update

Read more
8 Jan 2016 07:47

Vectura Group completes clinical trial, reveals US partner

(ShareCast News) - Vectura Group made a big step forward in the development of two of its products on Friday, VR315 and VR506, with the completion of a US clinical trial and the disclosure of its US development partner. The FTSE 250 firm described VR315 as a generic, inhaled combination therapy of f

Read more
8 Jan 2016 07:29

Vectura Group Completes Clinical Trial For VR315 Asthma Treatment

Read more
18 Dec 2015 14:10

Vectura Partner Ablynx Completes Enrolment For ALX-0171 Trial

Read more
15 Dec 2015 09:46

BROKER RATINGS SUMMARY: Berenberg Upgrades Meggitt To Buy From Hold

Read more
9 Dec 2015 07:55

Vectura Gets Milestone Payment As QVM149 Phase III Trial Begins

Read more
17 Nov 2015 08:45

Vectura Loss Narrows On Better Royalty Income, Seebri Results Good

Read more
17 Nov 2015 07:39

Higher royalties help lift Vectura interims

(ShareCast News) - Pharmaceutical group Vectura has posted a 57% rise in interim earnings before interest, tax, depreciation and amortisation to £4.7m driven by a 35% jump in revenues to £26.1m. Vectura, which specialises in products to treat airways-related diseases, trimmed its pre-tax losses to £

Read more
10 Nov 2015 16:01

Earnings, Trading Statements Calendar - Week Ahead

Read more
30 Oct 2015 16:54

LONDON MARKET CLOSE: Lower Close To Stellar October For Stocks

Read more
30 Oct 2015 12:17

LONDON MARKET MIDDAY: IAG Falls After Guidance Disappoints Market

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.